3D Bio Printing Market to grow at 12.9% CAGR through 2030 | Report by FMI

Academic institutes and hospitals use 3D printing technology to develop various models for training purposes. The technology is increasing used in bio printing where biomaterials such as growth factors and cells are combined with bioink to create tissue-like structures that imitate natural tissues. The global 3D bioprinting market is estimated to surpass US$ 1.2 Bn by 2021, at the market CAGR of 13% during the forecast period (2020-2030), as per a new report by Future Market Insights (FMI).

3D Bioprinting Market – About the Report

[290 Pages Report] Increasing rate of medical device manufacturing across the world has been fuelling the demand for advanced technologies. 3D bioprinting is used to design medical devices. Leading medical device and pharmaceutical manufacturing companies are focusing on improving their product portfolio across the world. The demand in this market is expected to surge in response to the lack of organ donors in adequate number. With research and development (R&D) investment within the medical devices sector poised to rise significantly, the market will gain from increasing growth opportunities in the coming years.

In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for 3D bioprinting. The report tracks the global sales of 3D bioprinting in 20+ high-growth markets, along with analyzing the impact COVID-19 has on the medical device industry in general, and 3D bioprinting in particular. COVID-19 pandemic will show a negative impact on the 3D bioprinting market. Due to short term shut down of production facilities of medical device industries for first few months in 2020

Get Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-808

3D bioprinting has immense potential to facilitate organ transplants and drug discovery. 3D printing can copy the actual macro and micro-environment of human organs and tissues which can solve the organ transplant crisis. Advancements in 3D printing technology and its promising applications in the healthcare industry are expected to increase the sale of 3D bioprinting over the forecast period.

As per the report, the technology will find increasing application in orthopedic implants manufacturing. The orthopedic implants segment is in fact forecast to account for over 30% of the market in terms of application.

Key Takeaways from 3D bioprinting Marker Study

  • Exhibiting a little below 13% Y-o-Y growth in 2021, 3D bioprinting market will exhibit solid growth
  • The U.S. will register high demand, accounting for nearly 95% of sales in North America
  • Demand in U.K. is expected to rise significantly, exhibiting above 11% Y-o-Y growth in 2021
  • France and Germany too will register high demand
  • In East Asia, China and Japan are expected to emerge as key market

“Launch of innovative 3D printers and application of 3D bioprinting in tissue engineering and regenerative medicine, medical device manufacturing will augment the growth of global 3D bioprinting market” says the FMI Analyst

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-808

Acquisitions, Partnerships and expansion are key Strategic Focus of 3D bioprinting Market Players

Leading players in the 3D bioprinting market on strengthening their market position though the Acquisition, Partnerships and expansion. For Instance,

  • In January 2021, 3D Systems announced its regenerative and bioprinting solutions expansion by actively investing in the regenerative areas, in collaboration with United Therapeutics Corporation.
  • In December 2019, GE Healthcare Life Sciences collaborated with Advanced Solutions Life Sciences (ASLS), a Kentucky-based biotechnology firm, to build an integrated 3D bioprinter by combining their digital advanced technologies.
  • In January 2020, GE Healthcare Life Sciences introduced a new additive manufacturing (AM) facility in Umeå, Sweden that will be dedicated to integrating 3D-printed parts into the company’s production of bio manufacturing equipment. With $2 million in backing, the new center is expected to increase biopharma manufacturers’ access to state-of-the-art technologies

Who is Winning?

The global market is set to expand its scope in the forecast period, due to rising prevalence of orthopedic disease globally and adoption of 3D bioprinting at various stages of development of orthopedic implants by medical manufacturers. In addition to this, cost effectiveness and increase adaption of 3D bioprinting in dental and regenerative medicine application has augmented the sales of 3D bioprinting.

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-808

The key market players covered by FMI include

  • 3D Systems, Inc
  • GE Healthcare (Concept Laser, Arcam AB)
  • EOS GmbH Electro Optical Systems
  • Renishaw plc
  • Stratasys Ltd
  • EnvisionTEC
  • Formlabs, Inc And Organovo Holdings Inc and
  • Advanced Solutions Life Sciences

consolidating their positions through mergers, acquisitions and new product launches.

3D bioprinting Market by Category

Technology

  • Stereolithography (SLA)
  • Selective Laser Sintering
  • Electron Beam Melting
  • Fused Deposition Modeling (FDM)
  • Laminated Object Manufacturing (LOM
  • Inkjet Printing
  • Multi-phase Jet Solidification

Application

  • Surgical Simulation and Training Models
  • Prosthetic Devices
  • Tissue Engineering and Regenerative Medicine
  • Orthopedic Implants
  • Dental Implants
  • Medical Sensors
  • Others

End User

  • Medical Device Manufacturers
  • Pharmaceutical Companies
  • Research & Academic Institutions
  • Contract Research Organizations

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Middle East and Africa (MEA)
  • Oceania

For Read More Related Insights:

http://healthcaremarket.blogsidea.com/16022539/systemic-lupus-erythematous-sle-drugs-market-to-reach-a-valuation-of-us-329-18-bn-by-2032
http://healthcare.ambien-blog.com/15936586/systemic-lupus-erythematous-sle-drugs-market-to-reach-a-valuation-of-us-329-18-bn-by-2032-at-a-5-cagr
https://aniket.dsiblogger.com/42283010/systemic-lupus-erythematous-sle-drugs-market-to-reach-a-valuation-of-us-329-18-bn-by-2032
https://todoist.com/app/project/2293699027/task/5949339487

About FMI:
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 8-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedInTwitterBlogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

About the Author

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these